Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease

Proceedings of the American Thoracic Society

Volumn 8, Issue 6, 2011, Pages 512-515

  Lee, Chun Geun ^a   Ma, Bing ^a   Takyar, Seyedtaghi ^a   Ahangari, Farida ^a   DelaCruz, Charles ^a   He, Chuan Hua ^a   Elias, Jack A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Mitochondrial antiviral signaling molecule; RIG like helicase; Virus

Indexed keywords

CYTOKINE; INTERLEUKIN 13; POLYINOSINIC POLYCYTIDYLIC ACID; VASCULOTROPIN;

ADAPTIVE IMMUNITY; AIRWAY; ANGIOGENESIS; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; INNATE IMMUNITY; MITOCHONDRION; NONHUMAN; PATHOGENESIS; VIRAL RESPIRATORY TRACT INFECTION;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80655125176     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201102-018MW     Document Type: Conference Paper

References (29)

1. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009;153:347-358.
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438: 932-936. (Pubitemid 43093958)
3. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000;106:783-791.
4. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438:967-974. (Pubitemid 43093963)
5. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances Th2-mediated sensitization and inflammation in the lung. Nat Med 2004;10:1095-1103. (Pubitemid 39424871)
6. Vogel C, Bauer A, Wiesnet M, Preissner KT, Schaper W, Marti HH, Fischer S. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-k/Akt pathway. J Cell Physiol 2007;212:236-243. (Pubitemid 46867606)
7. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000;106:1081-1093.
8. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788. (Pubitemid 29152623)
9. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001;107:1034-1038. (Pubitemid 32523344)
10. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301. (Pubitemid 32173907)
11. Ohta Y, Ohta N, Tamura M, Wu J, Tsunezuka Y, Oda M, Watanabe G. Vascular endothelial growth factor expression in airways of patients with lung cancer: a possible diagnostic tool of responsive angiogenic status on the host side. Chest 2002;121:1624-1627. (Pubitemid 34499680)
12. Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 2000;135:332-338. (Pubitemid 30213549)
13. Nishigaki Y, Fujiuchi S, Yamazaki Y, Matsumoto H, Takeda A, Fujita Y, Okamoto K, Fujikane T, Shimizu T, Kikuchi K. Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur Respir J 2003;21:774-778. (Pubitemid 36592283)
14. Kanazawa H, Hirata K, Yoshikawa J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 2002;57:885-888. (Pubitemid 35178614)
15. Asai K, Kanazawa H, Otani K, Shiraishi S, Hirata K, Yoshikawa J. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol 2002;110:571-575. (Pubitemid 35178791)
16. Lee CG, Yoon HJ, Zhu Z, Link H, Wang Z, Gwaltney JM, Landry M, Elias JA. Respiratory syncytial virus stimulation of vascular endothelial cell growth factor/vascular permeability factor. Am J Respir Cell Mol Biol 2000;23:662-669.
17. Ko FW, Ip M, Chan PK, Fok JP, Chan MC, Ngai JC, Chan DP, Hui DS. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007;131:44-52. (Pubitemid 46122973)
18. Mallia P, Contoli M, Caramori G, Pandit A, Johnston SL, Papi A. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Curr Pharm Des 2007;13:73-97. (Pubitemid 46085301)
19. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest 2006;130:1203-1210. (Pubitemid 44583754)
20. O'Gorman C, McHenry E, Coyle PV. Human metapneumovirus in adults: a short case series. Eur J Clin Microbiol Infect Dis 2006;25:190-192.
21. Sajjan US, Jia Y, Newcomb DC, Bentley JK, Lukacs NW, LiPuma JJ, Hershenson MB. H. Influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J 2006;20:2121-2123.
22. Sapey E, Stockley RA. COPD exacerbations. 2: aetiology. Thorax 2006; 61:250-258.
23. Farkas L, Farkas D, Ask K, Moller A, Gauldie J, Margetts P, Inman M, Kolb M. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest 2009;119:1298-1311.
24. Kurtagic E, Jedrychowski MP, Nugent MA. Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity. Am J Physiol Lung Cell Mol Physiol 2009;296:L534-L546.
25. Medford AR, Ibrahim NB, Millar AB. Vascular endothelial cell growth factor receptor and coreceptor expression in human acute respiratory distress syndrome. J Crit Care 2009;24:236-242.
26. Tuder RM, Yun JH. Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol 2008;8:255-260.
27. KangMJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008;118:2771-2784.
28. Ma B, De la Cruz CS, Hartl D, Kang M-J, Takyar S, Homer S, Lee CG, Elias JA. Rig-like helicase innate immunity inhibits VEGF tissue responses via a type I interferon-dependent mechanism. Am J Respir Crit Care Med 2011;183:1322-1335.
29. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, Koth LL, Arron JR, Fahy JV. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009;180:388-395.